Cargando…

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy

Mostrar otras versiones (1)

PURPOSE: The purpose of this study was to evaluate the predictive value of 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography (FDG-PET) following concurrent chemoradiotherapy (CRT) on survival in patients with carcinoma of the oropharynx (OPC). METHODS: Eighteen patients with primary OPC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Enomoto, Keisuke, Inohara, Hidenori, Higuchi, Ichiro, Hamada, Kenichiro, Tomiyama, Yoichiro, Kubo, Takeshi, Hatazawa, Jun
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2480511/ https://www.ncbi.nlm.nih.gov/pubmed/18528731 http://dx.doi.org/10.1007/s11307-008-0145-4

Ejemplares similares

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Small Cell Carcinoma of the Larynx Treated by Concurrent Chemoradiotherapy: A Case Report
por: Nakahara, Susumu, et al.
Publicado: (2012)

Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer
por: HASEGAWA, MASAHIRO, et al.
Publicado: (2014)

Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy
por: Hanamoto, Atsushi, et al.
Publicado: (2014)

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2011)

Pseudo-malignant paranasal invasive aspergillosis showing bone destruction and FDG uptake on PET/CT: A case report
por: Tsuda, Takeshi, et al.
Publicado: (2022)

Microscopic Residual Disease After Nasal Squamous Cell Carcinoma Not Visualized on FDG PET-CT: A Case Report
por: Tsuda, Takeshi, et al.
Publicado: (2023)

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy
por: Lee, Seokmo, et al.
Publicado: (2021)

Value of (18)F-FDG PET/CT for Assessment of Advanced Lacrimal Sac Non-Keratinizing Squamous Cell Carcinoma Successfully Treated with Concurrent Chemoradiotherapy
por: Liao, Ching-Yu, et al.
Publicado: (2021)

Assessment of Mediastinal Tumors Using SUV(max) and Volumetric Parameters on FDG-PET/CT
por: Morita, Takahiro, et al.
Publicado: (2017)

Prognostic value of quantitative FDG-PET in the prediction of survival and local recurrence for patients with advanced oral cancer treated with superselective intra-arterial chemoradiotherapy
por: Oyama, Tomoyuki, et al.
Publicado: (2020)

Prediction of response by FDG PET early during concurrent chemoradiotherapy for locally advanced non-small cell lung cancer
por: Kim, Suzy, et al.
Publicado: (2014)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

Prognostic value of 18F-FDG PET/MRI in patients with advanced oropharyngeal and hypopharyngeal squamous cell carcinoma
por: Pace, Leonardo, et al.
Publicado: (2021)

Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study
por: Yeh, Chih-Hua, et al.
Publicado: (2017)

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

Predictive Value of (18)F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
por: Yoo, Jang, et al.
Publicado: (2022)

Upfront DPYD Genotyping and Toxicity Associated with Fluoropyrimidine-Based Concurrent Chemoradiotherapy for Oropharyngeal Carcinomas: A Work in Progress
por: Desilets, Antoine, et al.
Publicado: (2022)

FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy
por: Day, F L, et al.
Publicado: (2011)

Human Papillomavirus and Cystic Node Metastasis in Oropharyngeal Cancer and Cancer of Unknown Primary Origin
por: Yasui, Toshimichi, et al.
Publicado: (2014)

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

Predictive and prognostic value of FDG-PET
por: de Geus-Oei, Lioe-Fee, et al.
Publicado: (2008)

Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer
por: Choi, Noah C., et al.
Publicado: (2013)

L-Glutamine and Survival of Patients with Locally Advanced Head and Neck Cancer Receiving Chemoradiotherapy
por: Tsujimoto, Takae, et al.
Publicado: (2023)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Empirical evaluation of variant calling accuracy using ultra-deep whole-genome sequencing data
por: Kishikawa, Toshihiro, et al.
Publicado: (2019)

Predictive and Prognostic Value of Metabolic Tumor Volume (MTV) in Patients with Laryngeal Carcinoma Treated by Radiotherapy (RT) / Concurrent Chemoradiotherapy (CCRT)
por: Yabuki, Kenichiro, et al.
Publicado: (2015)

Cancer Stem Cells in Oropharyngeal Cancer
por: Gunduz, Mehmet, et al.
Publicado: (2021)

Multiparametric imaging using (18)F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy
por: Chan, Sheng-Chieh, et al.
Publicado: (2017)

Combined pretreatment with (18)F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial
por: Ji, Shengjun, et al.
Publicado: (2018)

Prospective Analysis of (18)F-FDG PET/CT Predictive Value in Patients with Low Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Conservative Surgery
por: Niccoli-Asabella, Artor, et al.
Publicado: (2014)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Multimodality imaging with CT, MR and FDG-PET for radiotherapy target volume delineation in oropharyngeal squamous cell carcinoma
por: Bird, David, et al.
Publicado: (2015)

Concurrent chemotherapy in oropharyngeal cancer: Cisplatin wins
por: Amini, Arya, et al.
Publicado: (2019)

On the Added Value of Baseline FDG-PET in Malignant Lymphoma
por: Quarles van Ufford, Henriette, et al.
Publicado: (2009)

The Values and Limitations of FDG-PET/CT for Diagnosis of Hibernoma
por: Park, Jong Hoon, et al.
Publicado: (2015)

Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2019)

Diagnostic Accuracy of Combined PET/CT with MRI, 18F-FDG PET/MRI, and 18F-FDG PET/CT in Patients with Oropharyngeal and Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Kave, Mania, et al.
Publicado: (2021)

Correction: Multiparametric imaging using (18)F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy
por: Chan, Sheng-Chieh, et al.
Publicado: (2018)

Bronchopleural Fistula After Concurrent Chemoradiotherapy
por: van de Pas, Jorien M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hl880njp4o99fqvk5qh5vpltji